JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Qualcomm
QCOM
$197B
| $1.19B | 0.23% |
13,049,952
+1,705,521
| +15% | +$137M |
2013 Q2
28 quarters
|
|
102
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $1.18B | 0.23% |
10,575,344
+721,657
| +7% | +$71.1M |
2013 Q2
28 quarters
|
|
103
T. Rowe Price
TROW
$22.3B
| $1.18B | 0.23% |
9,585,627
-675,791
| -7% | -$77.1M |
2013 Q2
28 quarters
|
|
104
Fidelity National Information Services
FIS
$16.7B
| $1.17B | 0.23% |
8,761,537
-193,134
| -2% | -$25.4M |
2013 Q2
28 quarters
|
|
105
Lam Research
LRCX
$435B
| $1.17B | 0.23% |
36,205,460
+3,069,390
| +9% | +$83.7M |
2013 Q2
28 quarters
|
|
106
Constellation Brands
STZ
$19.3B
| $1.17B | 0.23% |
6,684,453
+309,113
| +5% | +$51.5M |
2013 Q2
28 quarters
|
|
107
ConocoPhillips
COP
$152B
| $1.17B | 0.23% |
27,785,134
-72,669
| -0.3% | -$2.94M |
2013 Q2
28 quarters
|
|
108
iShares MSCI Japan ETF
EWJ
$23.6B
| $1.13B | 0.22% |
20,575,079
+4,609,722
| +29% | +$245M |
2013 Q2
28 quarters
|
|
109
Regeneron Pharmaceuticals
REGN
$75.7B
| $1.12B | 0.22% |
1,797,470
+568,057
| +46% | +$322M |
2013 Q2
28 quarters
|
|
110
Zimmer Biomet
ZBH
$16.8B
| $1.11B | 0.21% |
9,544,579
+1,013,774
| +12% | +$117M |
2013 Q2
28 quarters
|
|
111
Lowe's Companies
LOW
$101B
| $1.1B | 0.21% |
8,127,435
+302,665
| +4% | +$34.6M |
2013 Q2
28 quarters
|
|
112
iShares MBS ETF
MBB
$36.6B
| $1.09B | 0.21% |
9,883,340
+425,668
| +5% | +$47.1M |
2013 Q2
28 quarters
|
|
113
NXP Semiconductors
NXPI
$61.4B
| $1.08B | 0.21% |
9,444,760
+2,766,363
| +41% | +$277M |
2013 Q3
27 quarters
|
|
114
Equinix
EQIX
$101B
| $1.07B | 0.21% |
1,529,901
+36,298
| +2% | +$24.6M |
2014 Q3
23 quarters
|
|
115
General Dynamics
GD
$89.3B
| $1.07B | 0.21% |
7,155,006
-429,604
| -6% | -$60.7M |
2013 Q2
28 quarters
|
|
116
Visa
V
$677B
| $1.07B | 0.21% |
5,524,274
-205,934
| -4% | -$37.6M |
2013 Q2
28 quarters
|
|
117
iShares US Treasury Bond ETF
GOVT
$41.2B
| $1.07B | 0.21% |
38,092,104
+9,530,041
| +33% | +$267M |
2015 Q4
18 quarters
|
|
118
Accenture
ACN
$122B
| $1.06B | 0.2% |
4,935,350
-682,405
| -12% | -$129M |
2013 Q2
28 quarters
|
|
119
Dover
DOV
$25.5B
| $1.06B | 0.2% |
10,968,061
+1,100,560
| +11% | +$102M |
2013 Q2
28 quarters
|
|
120
EPAM Systems
EPAM
$5.59B
| $1.05B | 0.2% |
4,172,412
+201,836
| +5% | +$44.4M |
2013 Q3
27 quarters
|
|
121
Cisco
CSCO
$442B
| $1.01B | 0.2% |
21,703,438
+1,565,272
| +8% | +$68.6M |
2013 Q2
28 quarters
|
|
122
Northrop Grumman
NOC
$67.9B
| $1B | 0.19% |
3,258,726
+149,042
| +5% | +$48.9M |
2013 Q2
28 quarters
|
|
123
Intuitive Surgical
ISRG
$138B
| $989M | 0.19% |
5,205,186
-77,529
| -1% | -$13.9M |
2013 Q2
28 quarters
|
|
124
PUT
Tesla
TSLA
$1.46T
| $984M | 0.19% |
13,675,500
-4,980,000
| -27% | -$269M |
2014 Q3
23 quarters
|
|
125
Best Buy
BBY
$18.4B
| $978M | 0.19% |
11,201,847
+3,588,247
| +47% | +$272M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.